| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Arctigenin | Hepatic Fibrosis | 2 | PM | 38679116 | 📋 | Arctigenin induces activated HSCs quiescence via AMPK-PPARγ pathway to ameliorate liver fibrosis in mice |
| Arctigenin | Hepatic Fibrosis | 1 | PM | 25498792 | 📋 | The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway |
| Arctigenin | Kidney Fibrosis | 1 | PM | 28545667 | 📋 | Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy |
| Arctigenin | Kidney Fibrosis | 2 | PM | 25968940 | 📋 | Arctigenin suppresses transforming growth factor-β1-induced expression of monocyte chemoattractant protein-1 and the subsequent epithelial-mesenchymal transition through reactive oxygen species-dependent ERK/NF-κB signaling pathway in renal tubular epithelial cells |
| Arctigenin | Oral Submucous Fibrosis | 1 | PM | 30884781 | 📋 | Arctigenin Reduces Myofibroblast Activities in Oral Submucous Fibrosis by LINC00974 Inhibition |
| Arctigenin | Peritoneal Fibrosis | 1 | PM | 31607474 | 📋 | Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells |
| Arctigenin | Pulmonary Fibrosis | 1 | PM | 35847593 | 📋 | Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity |
| Arctigenin | Pulmonary Fibrosis | 2 | PM | 33390951 | 📋 | Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis |
